# Three-Pillar Analytics Transformation Playbook

**Version:** 1.0
**Status:** DRAFT
**Target Audience:** CIO, CMIO, CTO
**Objective:** Operationalize the "Three-Pillar Framework" while mitigating risks of institutional memory loss and schema drift.

---

## Phase 1: The "Truth" Audit (Diagnostics)

Before deploying any NL2SQL or AI analytics, we must establish a baseline of our operational reality. The paper's reliance on 2004 data is a critical gap; we must measure our *current* state.

### Workforce Reality Check
To quantify "Institutional Memory Loss," HR and IT must calculate these three metrics immediately:
*   **Analyst Turnover Rate (ATR):** `(Departures / Average Headcount) * 100` over the last 24 months. *Threshold: >15% indicates critical memory leakage.*
*   **Knowledge Artifact Ratio (KAR):** `(Verified Documentation Pages / Total SQL Queries in Production)`. *Threshold: <0.1 indicates "Tribal Knowledge" dependency.*
*   **Onboarding Velocity:** Average days for a new analyst to ship their first error-free production query. *Threshold: >45 days indicates structural complexity barrier.*

### Technical Readiness: "Red Flag" Criteria
Do **NOT** attempt NL2SQL implementation in any clinical domain matching these criteria:
*   **Missing Data Dictionary:** Less than 80% of tables/columns have user-friendly descriptions in the metadata repository.
*   **Non-Standard Vocabulary:** Reliance on local custom codes (e.g., "Mega-Code") instead of standard ontologies (ICD-10, SNOMED, LOINC) for >20% of fields.
*   **Ghost Tables:** Reliance on deprecated or "temp" tables for core reporting logic.

## Phase 2: Solving the "Validator Paradox" (Governance)

We cannot assume experts exist to validate every AI query. We must enforce a governance model that assumes fallibility.

### Tiered Trust Protocol
All AI-generated queries must be classified into one of three tiers based on risk:
*   **Tier 3: Exploratory (Sandbox Only):**
    *   *Scope:* Ad-hoc data exploration, hypothesis generation.
    *   *Access:* Read-only access to de-identified data.
    *   *Validation:* Self-service; user assumes all risk. NO decision-making permitted.
*   **Tier 2: Operational (Departmental):**
    *   *Scope:* Internal staffing reports, supply chain, non-clinical workflows.
    *   *Validation:* Peer review by one Senior Analyst required before automation.
*   **Tier 1: Clinical Safety (Gold Standard):**
    *   *Scope:* Patient care decisions, quality reporting, external submission.
    *   *Validation:* Dual-signature required (Clinical Subject Matter Expert + Lead Data Engineer). *Zero tolerance for unverified AI code.*

### The "Human-in-the-Loop"
To promote a query to "Gold Standard," the validator must meet these specific qualifications. We must avoid "the blind leading the blind":
*   **Role:** **Clinical Data Steward** (new role or designated lead).
*   **Qualification:** Minimum 3 years experience with the specific EHR schema (e.g., Epic Clarity/Caboodle certified) AND clinical workflow certification.
*   **Responsibility:** Personally liable for the semantic accuracy of the query logic.

## Phase 3: "QueryOps" (Technical Operations)

Static SQL queries are technical debt. We must treat Knowledge as Code.

### Managing Schema Drift: Continuous Knowledge Integration
When the EHR schema updates (e.g., quarterly upgrades), our system must fail safely:
1.  **Automated Regression Testing:** Every "Gold Standard" query is stored with its original Natural Language question AND a synthetic "Test Data" expectation.
2.  **Pre-Upgrade Dry Run:** Run all stored queries against the upgrade preview environment.
3.  **Drift Detection:** If the result set schema or row count variance exceeds 5%, the query is automatically flagged as **"BROKEN/UNVERIFIED"** and disabled in the UI until re-validated.

### Staleness Policy
*   **Auto-Archive:** Any query not executed or re-validated in **180 days** is automatically moved to "Archived" status.
*   **Forced Re-validation:** "Gold Standard" queries must be explicitly re-signed annually by the Data Steward.

## Phase 4: Vendor-Neutral Implementation Strategy

### Build vs. Buy vs. Wait Decision Matrix
| Factor | **Buy (Vendor Solution)** | **Build (Open Source/In-House)** | **Wait (Defer)** |
| :--- | :--- | :--- | :--- |
| **Data Maturity** | High (Standard models) | Moderate (Custom schemas) | Low (Messy data) |
| **Risk Tolerance** | Low | Moderate | Zero |
| **Budget** | Opex (Subscription) | Capex (Talent) | N/A |
| **Urgency** | Immediate | Long-term Strategic | None |

### Pilot Selection: Revenue Cycle (Billing)
**Recommendation:** Start with **Billing/Revenue Cycle Management**.
*   **Why:**
    *   **Low Safety Risk:** Errors result in financial adjustments, not patient harm.
    *   **High Structure:** Billing data is highly standardized (CPT/ICD codes) compared to messy clinical notes.
    *   **Clear ROI:** Measurable impact on days-in-AR or denial rates establishes immediate value to leadership.
    *   **Feedback Loop:** Denials provide ground-truth labels for model improvement.

---
*Generated for YuiQuery Project - Internal Use Only*
